Literature DB >> 20650983

Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia.

M Pifferi1, A Bush, D Caramella, M Di Cicco, M Zangani, I Chinellato, P Macchia, A L Boner.   

Abstract

Agenesis of paranasal sinuses has only been described in case reports of patients with primary ciliary dyskinesia (PCD). As agenesis of paranasal sinuses may contribute to low nasal nitric oxide levels, a common finding in PCD, we speculated that this condition might frequently occur in PCD patients. Patients referred for PCD evaluation were consecutively recruited for 30 months. In addition to standard diagnostic testing for PCD, a computed tomography (CT) scan of paranasal sinuses was performed in all subjects. 86 patients (46 children aged 8-17 yrs) were studied. PCD was diagnosed in 41 subjects and secondary ciliary dyskinesia (SCD) was diagnosed in the remaining 45 subjects. Frontal and/or sphenoidal sinuses were either aplastic or hypoplastic on CT scans in 30 (73%) out of 41 PCD patients, but in only 17 (38%) out of 45 with SCD (p = 0.002). There was a significant inverse correlation between the score for aplasia/hypoplasia of each paranasal sinus and nasal NO values in the PCD patients (p = 0.008, r = -0.432) but not in SCD (p = 0.07, r = -0.271). The findings of aplasia/hypoplasia of the frontal and or sphenoidal sinuses may be part of the spectrum of PCD and this finding should prompt exclusion of this condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650983     DOI: 10.1183/09031936.00068810

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

Review 1.  Primary ciliary dyskinesia, an orphan disease.

Authors:  Mieke Boon; Mark Jorissen; Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

2.  Nasal nitric oxide is an important test in the diagnostic pathway for primary ciliary dyskinesia.

Authors:  Jane S Lucas; Woolf T Walker
Journal:  Ann Am Thorac Soc       Date:  2013-12

Review 3.  Anatomical variations of the sphenoid sinus and its adjacent structures: a review of existing literature.

Authors:  B Anusha; A Baharudin; R Philip; S Harvinder; B Mohd Shaffie
Journal:  Surg Radiol Anat       Date:  2013-10-22       Impact factor: 1.246

4.  Endoscopic sinus surgery for treatment of kartagener syndrome: a case report.

Authors:  Xinghua Tang; Jian Zou; Shixi Liu
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

5.  Accuracy and precision of manual segmentation of the maxillary sinus in MR images-a method study.

Authors:  Tobias N Andersen; Tron A Darvann; Shumei Murakami; Per Larsen; Yurie Senda; Anders Bilde; Christian V Buchwald; Sven Kreiborg
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

6.  Primary Ciliary Dyskinesia (PCD): A genetic disorder of motile cilia.

Authors:  Margaret W Leigh; Amjad Horani; BreAnna Kinghorn; Michael G O'Connor; Maimoona A Zariwala; Michael R Knowles
Journal:  Transl Sci Rare Dis       Date:  2019-07-04

Review 7.  Clinical spectrum of primary ciliary dyskinesia in childhood.

Authors:  Andrew Fretzayas; Maria Moustaki
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 8.  Prevalence of primary ciliary dyskinesia in consecutive referrals of suspect cases and the transmission electron microscopy detection rate: a systematic review and meta-analysis.

Authors:  Panayiotis Kouis; Panayiotis K Yiallouros; Nicos Middleton; John S Evans; Kyriacos Kyriacou; Stefania I Papatheodorou
Journal:  Pediatr Res       Date:  2016-12-09       Impact factor: 3.756

9.  Clinical value of measurement of pulmonary radioaerosol mucociliary clearance in the work up of primary ciliary dyskinesia.

Authors:  Mathias Munkholm; Kim Gjerum Nielsen; Jann Mortensen
Journal:  EJNMMI Res       Date:  2015-07-16       Impact factor: 3.138

10.  Total aplasia of the paranasal sinuses.

Authors:  Hakan Korkmaz; Mukadder Korkmaz
Journal:  Allergy Rhinol (Providence)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.